All Articles

Federal funding to be announced in Innisfail aims to spur job creation, cut emissions, and cement Alberta's role as a leader in energy innovation.

The low-sugar pioneer launches new fruit snacks, leveraging its brand power to challenge incumbents in a market ripe for healthier alternatives.

A new collaboration between LSEG and RiskSpan aims to set a new standard for transparency and accuracy in pricing complex assets like MBS and ABS.

The tech firm is buying back nearly half its shares. We analyze if this massive tender offer is a bold bet on its AI future or a retreat from growth.

Beyond the headline numbers, CMC's stellar Q3 results reveal a masterclass in strategic execution, with key acquisitions and new EU policies fueling growth.

A new CMS program offers seniors blockbuster obesity drugs for $50. But this temporary fix raises profound questions about cost, access, and our healthcare future.

AgileAI Labs' new tool lets non-coders test software in plain English, aiming to finally bridge the costly gap between human ideas and flawless code.

A small investment in Quebec's biofood sector reveals a larger strategy: fortifying Canada's food sovereignty as a core pillar of national security.

GFL Environmental's entry into the Russell 1000 isn't just news; it's the result of a calculated strategic shift south, unlocking massive investor access.

deBCor Engineering's new Excel-native SAP pricing tool promises to slash update times. But this is more than efficiency—it’s the critical first step to an AI-driven future.

Amid high inflation, Iceland's Landsbankinn offers new covered bonds. We analyze the strategy, investor appeal, and what this signals for the Nordic market.

Amidst soaring anxiety and burnout, one Hong Kong practice is rewriting the rules of therapy with cultural fluency and therapists who've lived the grind.

Today's housing announcement in St. Catharines is more than local news; it's a key signal in the federal government's national investment strategy.

Sterling Bank of Asia is ditching legacy systems for Infosys Finacle's cloud platform. This isn't just a tech deal; it's a blueprint for the future.

Insmed and EMBARC's 3,000-patient study of brensocatib aims to do more than treat a chronic lung disease—it aims to fundamentally alter its course.

As drone threats escalate, Finland partners with Nokia to build a nationwide counter-drone network, transforming border security with advanced connectivity.

AGIBOT's new partnership with VST ECS aims to deploy humanoid robots at scale in Thailand, promising a productivity boom but raising critical questions for the future of work.

With $8M from top VCs, Sazabi is deploying AI agents to fix software bugs before humans can. Can their radical 'logs-only' approach dethrone giants?

As Ottawa unveils a new housing plan for Hamilton, it's more than local news. It's a crucial look into the federal playbook for tackling Canada's affordability crisis.

IBM unveils a 0.7nm chip with a revolutionary 'nanostack' 3D architecture, packing 100 billion transistors and promising a new decade for Moore's Law.